CIS: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in CIS

After four years of growth, the CIS human and animal blood market decreased by X% to $X in 2022. Overall, consumption, however, showed temperate growth. Over the period under review, the market hit record highs at $X in 2021, and then reduced rapidly in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in CIS

In value terms, human and animal blood production reached $X in 2022 estimated in export price. The total production indicated measured growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2017 when the production volume increased by X%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in CIS

In 2022, human and animal blood exports in the CIS reduced sharply to X tons, which is down by X% on 2021. Total exports indicated a modest increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports decreased by X% against 2019 indices. The growth pace was the most rapid in 2013 with an increase of X%. Over the period under review, the exports hit record highs at X tons in 2019; however, from 2020 to 2022, the exports failed to regain momentum.

In value terms, human and animal blood exports skyrocketed to $X in 2022. Overall, exports, however, recorded resilient growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

Russia prevails in exports structure, recording X tons, which was near X% of total exports in 2022. Belarus (X tons) took a minor share of total exports.

Russia was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports, with a CAGR of X% from 2012 to 2022. Belarus (X%) illustrated a downward trend over the same period. While the share of Russia (X p.p.) increased significantly in terms of the total exports from 2012-2022, the share of Belarus (X p.p.) displayed negative dynamics.

In value terms, Russia ($X) remains the largest human and animal blood supplier in the CIS, comprising X% of total exports. The second position in the ranking was held by Belarus ($X), with a X% share of total exports.

In Russia, human and animal blood exports increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

The export price in the CIS stood at $X per ton in 2022, surging by X% against the previous year. Overall, the export price enjoyed a resilient increase. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Russia ($X per ton), while Belarus stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Russia (X%).

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in CIS

In 2022, human and animal blood imports in the CIS fell rapidly to X tons, with a decrease of X% on 2021. Over the period under review, imports, however, saw a mild increase. The pace of growth appeared the most rapid in 2016 with an increase of X%. Over the period under review, imports attained the peak figure at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, human and animal blood imports shrank rapidly to $X in 2022. In general, imports saw a mild descent. The growth pace was the most rapid in 2016 with an increase of X% against the previous year. Over the period under review, imports hit record highs at $X in 2020; however, from 2021 to 2022, imports failed to regain momentum.

Imports by Country

Russia represented the main importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the CIS, with the volume of imports recording X tons, which was approx. X% of total imports in 2022. Kazakhstan (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Uzbekistan (X%) and Belarus (X%). Moldova (X tons) and Azerbaijan (X tons) held a little share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Azerbaijan (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the CIS, comprising X% of total imports. The second position in the ranking was taken by Uzbekistan ($X), with a X% share of total imports. It was followed by Kazakhstan, with a X% share.

In Russia, human and animal blood imports plunged by an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Uzbekistan (X% per year) and Kazakhstan (X% per year).

Import Prices by Country

In 2022, the import price in the CIS amounted to $X per ton, rising by X% against the previous year. Over the period under review, the import price, however, continues to indicate a noticeable descent. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. Over the period under review, import prices attained the maximum at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Russia ($X per ton), while Moldova ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Russia (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :